Tokyo, July 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062108) titled 'Development of a prognostic prediction model for anti-amyloid antibody therapy in Alzheimer's disease' on July 10.
Study Type:
Observational
Primary Sponsor:
Institute - Kansai Medical University
Condition:
Condition - Mild cognitive impairment, dementia
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to prospectively enroll patients with Alzheimer's disease or suspected Alzheimer's disease who are considered for initiation, discontinuation, or resumption of anti-amyloid antibody therapy at Kansai Medical University Hospital and Kansai Medical Uni...